BCI and FES for Hand Therapy in Spinal Cord Injury

Spinal Cord Injury Clinical Trial

Official title:

Brain Computer Interface Control of Functional Electrical Stimulation for a Hand Therapy in Tetraplegic Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01852279
• Other study ID #: GN12NE574
• Status: Completed
• Phase: N/A
• Start date: May 8, 2013
• Est. completion date: December 31, 2018

Study information

• Verified date: December 2020
• Source: NHS Greater Glasgow and Clyde
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will assess whether functional recovery of the hand muscles in patients with spinal cord injury is enhanced when electrical stimulation of the muscles is delivered actively by means of using the electroencephalography wave patterns arising from the patient imagining moving their hand to operate the stimulator. A control group will obtain the electrical stimulation treatment passively by a therapist operating the machine.

Description:

Injuries of the higher levels of the spinal cord, called tetraplegia, result in a complete or partial paralysis of both legs and arms, making the person dependent on their caregivers for elementary activities of daily living (ADL) such as drinking and feeding. About 60% of tetraplegics have an incomplete injury and can partially recover their movement and sensation. The success of a recovery greatly depends on the therapy within the first year after the injury. Functional electrical stimulation (FES) is a relatively novel therapy of the hand. In FES therapy electrodes are attached on the surface the patients's forearms and electrical current is delivered through them. A disadvantage of the current FES therapy is that a therapist has to switch the stimulator on and off because patients cannot use either of their hands. In our previous pilot study performed on two acute tetraplegic patients we tested feasibility of using brain-computer interface (BCI) to control FES on patient's will. BCI is based on recording the patient's brain activity. BCI can detect the patient's intention to move the hand even if they are not able to physically move it. Using BCI, patients control the FES by thinking to move their hand.

A BCI-FES therapy will provide a simultaneous training of neural pathways from the brain to the hand muscle (motor imagination/attempt) and from the muscle to the brain (electrical stimulation of muscles). This form of therapy could promote faster and more complete recovery

In this controlled study we aim to provide a BCI-FES therapy to both chronic and subacute tetraplegic patients over a period of 20 sessions and to access the functional and neurological outcome of the therapy. Five chronic patients (more than a year after the injury) will participate in a cross-over study as we do not expect that they will recover spontaneously without BCI-FES. Subacute patients will be receiving both a conventional therapy and BCI-FES so recovery can be caused by either of these two therapies. Therefore it is necessary to have a treatment and a control group. Each group will have 10 patients, age and injury matched. Both groups will receive the same amount of electrical stimulation but only the treatment group will voluntarily control the electrical stimulator using BCI. A control group will receive passive electrical stimulation of the same hand muscles but without using BCI.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: December 31, 2018
• Est. primary completion date: December 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• incomplete (ASIA B, C) tetraplegia with injury at level C4-C8

• aged between 18 and 70 years old

• a candidate suitable for the conventional therapy

Exclusion Criteria:

• Patients must not have presence of any neurological problem that might distort recording standard brain signal during motor imagination (example: brain damage, epilepsy, Parkinson disease and multiple sclerosis)

• Patients must not have cognitive impairments (hearing, vision and general inability to understand instructions)

• Patients must not suffer from recurring pressure sore which prevent patient from sitting for at least an hour

• Patients must not suffer from excessive spasm that would increase with electrical stimulation.

Related Conditions & MeSH terms

• Spinal Cord Injuries
• Spinal Cord Injury

Intervention

Device:
• BCI-FES
Brain computer Interface delivered Function Electrical Stimulation
• Passive muscle stimulation
Functional Electrical stimulation delivered by therapist

Locations

Country	Name	City	State
United Kingdom	Queen Elizabeth National Spinal Injuries Unit	Glasgow

Sponsors (2)

Lead Sponsor	Collaborator
NHS Greater Glasgow and Clyde	University of Glasgow

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Muscle strength as measured by the Oxford manual test		Between initial and final assessment after up to 8 weeks of treatment
Secondary	Changes in patients EEG before and after each treatment session	Measures will be taken at the beginning and end of each of the 20 treatment sessions	between beginning and end of each one hour treatment session
Secondary	Difference in EEG between the treatment and the control group		Between initial and final assessment after up to 8 weeks of treatment
Secondary	Difference in Somatosensory evoked potential between the treatment and control group		Between initial and final assessment after up to 8 weeks of treatment
Secondary	Difference in somatosensory evoked potential before and after a treatment session		Between initial and final assessment after up to 8 weeks of treatment
Secondary	Patient's experience of using BCI-FES	A questionnaire will collect information	Between initial and final assessment after up to 8 weeks of treatment
Secondary	Quadriplegia index of function		Between initial and final assessment after up to 8 weeks of treatment
Secondary	Range of movement of wrists and fingers		Between initial and final assessment after up to 8 weeks of treatment